AVAH - Aveanna Healthcare... Stock Analysis | Stock Taper
Logo
Aveanna Healthcare Holdings Inc.

AVAH

Aveanna Healthcare Holdings Inc. NASDAQ
$6.69 -0.45% (-0.03)

Market Cap $1.46 B
52w High $10.32
52w Low $3.73
P/E 6.37
Volume 933.24K
Outstanding Shares 217.51M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $662.48M $133.3M $178.75M 26.98% $0.88 $80M
Q3-2025 $621.94M $143.95M $14.06M 2.26% $0.07 $55.67M
Q2-2025 $589.55M $130.77M $27.02M 4.58% $0.13 $87.11M
Q1-2025 $559.22M $131.76M $5.19M 0.93% $0.03 $51.78M
Q4-2024 $519.87M $125.95M $29.18M 5.61% $0.15 $70.57M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $193.26M $2.03B $1.83B $194.46M
Q3-2025 $145.87M $1.81B $1.8B $9.91M
Q2-2025 $100.74M $1.77B $1.78B $-11.26M
Q1-2025 $71.49M $1.66B $1.76B $-98.67M
Q4-2024 $84.29M $1.66B $1.79B $-122.09M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $178.75M $49.72M $-1.95M $-377K $47.39M $55.22M
Q3-2025 $14.06M $33.2M $-2.02M $13.95M $45.13M $31.18M
Q2-2025 $27.02M $51.57M $-15.98M $-6.34M $29.24M $50.44M
Q1-2025 $5.19M $-8.63M $-2.35M $-1.81M $-12.79M $-10.98M
Q4-2024 $29.18M $13.41M $-1.53M $-6.05M $5.83M $11.88M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Home Health And Hospice
Home Health And Hospice
$60.00M $60.00M $60.00M $70.00M
Medical Solutions
Medical Solutions
$40.00M $40.00M $50.00M $50.00M
Private Duty Services
Private Duty Services
$460.00M $490.00M $510.00M $540.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Aveanna Healthcare Holdings Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Aveanna combines meaningful scale, strong current‑period profitability, and solid operating and free cash flow with a distinctive niche in high‑acuity pediatric and complex‑care home services. Its technology‑enabled platform, specialized clinical programs, and growing network of preferred payer relationships provide strategic advantages that many smaller or less specialized competitors may struggle to match.

! Risks

The company’s financial structure is fragile: high debt, negative equity, and tight liquidity create heightened sensitivity to any downturn in cash flows or reimbursement. A balance sheet dominated by goodwill and intangibles underscores reliance on past acquisitions, which may be vulnerable to impairment if performance slips. Sector‑wide headwinds—labor shortages, wage pressure, and reimbursement risk—compound these issues, and limited visible reinvestment raises questions about long‑term growth and asset renewal.

Outlook

The outlook hinges on Aveanna’s ability to sustain current profitability and cash generation while gradually strengthening its balance sheet and continuing to leverage its technology and specialization. If operational improvements and value‑based partnerships continue to gain traction, the business has the ingredients for stable or improving performance in a growing home‑care market. At the same time, elevated leverage and structural industry challenges mean the path forward is likely to be sensitive to execution quality and broader policy and labor trends, leaving both upside and downside scenarios very plausible.